liu.seSearch for publications in DiVA
Change search
Link to record
Permanent link

Direct link
Alternative names
Publications (9 of 9) Show all publications
Linmans, J., Raya, G., van der Laak, J. & Litjens, G. (2024). Diffusion models for out-of-distribution detection in digital pathology. Medical Image Analysis, 93, Article ID 103088.
Open this publication in new window or tab >>Diffusion models for out-of-distribution detection in digital pathology
2024 (English)In: Medical Image Analysis, ISSN 1361-8415, E-ISSN 1361-8423, Vol. 93, article id 103088Article in journal (Refereed) Published
Abstract [en]

The ability to detect anomalies, i.e. anything not seen during training or out -of -distribution (OOD), in medical imaging applications is essential for successfully deploying machine learning systems. Filtering out OOD data using unsupervised learning is especially promising because it does not require costly annotations. A new class of models called AnoDDPMs, based on denoising diffusion probabilistic models (DDPMs), has recently achieved significant progress in unsupervised OOD detection. This work provides a benchmark for unsupervised OOD detection methods in digital pathology. By leveraging fast sampling techniques, we apply AnoDDPM on a large enough scale for whole -slide image analysis on the complete test set of the Camelyon16 challenge. Based on ROC analysis, we show that AnoDDPMs can detect OOD data with an AUC of up to 94.13 and 86.93 on two patch -level OOD detection tasks, outperforming the other unsupervised methods. We observe that AnoDDPMs alter the semantic properties of inputs, replacing anomalous data with more benign -looking tissue. Furthermore, we highlight the flexibility of AnoDDPM towards different information bottlenecks by evaluating reconstruction errors for inputs with different signal-to-noise ratios. While there is still a significant performance gap with fully supervised learning, AnoDDPMs show considerable promise in the field of OOD detection in digital pathology.

Place, publisher, year, edition, pages
ELSEVIER, 2024
Keywords
Denoising diffusion probabilistic models; Out-of-distribution detection; Deep learning; Histopathology; Unsupervised learning
National Category
Medical Imaging
Identifiers
urn:nbn:se:liu:diva-201188 (URN)10.1016/j.media.2024.103088 (DOI)001162372700001 ()38228075 (PubMedID)2-s2.0-85182406832 (Scopus ID)
Note

Funding Agencies|Innovative Medicines Initiative 2 Joint Undertaking [945358]; European Union's Horizon 2020 research and innovation program; EFPIA; Dutch Cancer Society (KWF) [KUN 2015-7970]; Dutch Research Council (NWO) [91618152, 17998]; Knut and Alice Wallenberg foundation

Available from: 2024-02-26 Created: 2024-02-26 Last updated: 2025-03-13Bibliographically approved
Smit, M. A., Ciompi, F., Bokhorst, J.-M., van Pelt, G. W., Geessink, O. G. .., Putter, H., . . . van der Laak, J. (2023). Deep learning based tumor–stroma ratio scoring in colon cancer correlates with microscopic assessment. Journal of Pathology Informatics, 14, Article ID 100191.
Open this publication in new window or tab >>Deep learning based tumor–stroma ratio scoring in colon cancer correlates with microscopic assessment
Show others...
2023 (English)In: Journal of Pathology Informatics, ISSN 2229-5089, E-ISSN 2153-3539, Vol. 14, article id 100191Article in journal (Refereed) Published
Abstract [en]

Background: The amount of stroma within the primary tumor is a prognostic parameter for colon cancer patients. This phenomenon can be assessed using the tumor–stroma ratio (TSR), which classifies tumors in stroma-low (≤50% stroma) and stroma-high (>50% stroma). Although the reproducibility for TSR determination is good, improvement might be expected from automation. The aim of this study was to investigate whether the scoring of the TSR in a semi- and fully automated method using deep learning algorithms is feasible. Methods: A series of 75 colon cancer slides were selected from a trial series of the UNITED study. For the standard determination of the TSR, 3 observers scored the histological slides. Next, the slides were digitized, color normalized, and the stroma percentages were scored using semi- and fully automated deep learning algorithms. Correlations were determined using intraclass correlation coefficients (ICCs) and Spearman rank correlations. Results: 37 (49%) cases were classified as stroma-low and 38 (51%) as stroma-high by visual estimation. A high level of concordance between the 3 observers was reached, with ICCs of 0.91, 0.89, and 0.94 (all P < .001). Between visual and semi-automated assessment the ICC was 0.78 (95% CI 0.23–0.91, P-value 0.005), with a Spearman correlation of 0.88 (P < .001). Spearman correlation coefficients above 0.70 (N=3) were observed for visual estimation versus the fully automated scoring procedures. Conclusion: Good correlations were observed between standard visual TSR determination and semi- and fully automated TSR scores. At this point, visual examination has the highest observer agreement, but semi-automated scoring could be helpful to support pathologists. © 2023 The Authors

Place, publisher, year, edition, pages
Elsevier B.V., 2023
National Category
Cancer and Oncology
Identifiers
urn:nbn:se:liu:diva-200781 (URN)10.1016/j.jpi.2023.100191 (DOI)36794267 (PubMedID)2-s2.0-85147290457 (Scopus ID)
Available from: 2024-02-07 Created: 2024-02-07 Last updated: 2024-12-02
Bulten, W., Kartasalo, K., Chen, P.-H. C., Ström, P., Pinckaers, H., Nagpal, K., . . . Eklund, M. (2022). Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge. Nature Medicine, 28(1), 154-163
Open this publication in new window or tab >>Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
Show others...
2022 (English)In: Nature Medicine, ISSN 1078-8956, E-ISSN 1546-170X, Vol. 28, no 1, p. 154-163Article in journal (Refereed) Published
Abstract [en]

Through a community-driven competition, the PANDA challenge provides a curated diverse dataset and a catalog of models for prostate cancer pathology, and represents a blueprint for evaluating AI algorithms in digital pathology. Artificial intelligence (AI) has shown promise for diagnosing prostate cancer in biopsies. However, results have been limited to individual studies, lacking validation in multinational settings. Competitions have been shown to be accelerators for medical imaging innovations, but their impact is hindered by lack of reproducibility and independent validation. With this in mind, we organized the PANDA challenge-the largest histopathology competition to date, joined by 1,290 developers-to catalyze development of reproducible AI algorithms for Gleason grading using 10,616 digitized prostate biopsies. We validated that a diverse set of submitted algorithms reached pathologist-level performance on independent cross-continental cohorts, fully blinded to the algorithm developers. On United States and European external validation sets, the algorithms achieved agreements of 0.862 (quadratically weighted kappa, 95% confidence interval (CI), 0.840-0.884) and 0.868 (95% CI, 0.835-0.900) with expert uropathologists. Successful generalization across different patient populations, laboratories and reference standards, achieved by a variety of algorithmic approaches, warrants evaluating AI-based Gleason grading in prospective clinical trials.

Place, publisher, year, edition, pages
Nature Portfolio, 2022
National Category
Cancer and Oncology
Identifiers
urn:nbn:se:liu:diva-182759 (URN)10.1038/s41591-021-01620-2 (DOI)000742323900003 ()35027755 (PubMedID)2-s2.0-85122887634 (Scopus ID)
Note

Funding Agencies|Dutch Cancer SocietyKWF Kankerbestrijding [KUN 2015-7970]; Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [016.186.152]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [201901466, 2020-00692]; Swedish Cancer Society (CAN)Swedish Cancer Society [2018/741]; Swedish eScience Research Center; Ake Wiberg Foundation; Prostatacancerforbundet; Academy of FinlandAcademy of FinlandEuropean Commission [341967, 335976]; Cancer Foundation Finland; Google LLCGoogle Incorporated; MICCAI board challenge working group; Verily Life Sciences; EIT Health; Karolinska InstitutetKarolinska Institutet; MICCAI 2020 satellite event team; ERAPerMed [334782]

Available from: 2022-02-10 Created: 2022-02-10 Last updated: 2023-03-31Bibliographically approved
van der Kamp, A., Waterlander, T. J., de Bel, T., van der Laak, J., van den Heuvel-Eibrink, M. M., Mavinkurve-Groothuis, A. M. C. & de Krijger, R. R. (2022). Artificial Intelligence in Pediatric Pathology: The Extinction of a Medical Profession or the Key to a Bright Future?. Pediatric and Developmental Pathology, 25(4), 380-387, Article ID 10935266211059809.
Open this publication in new window or tab >>Artificial Intelligence in Pediatric Pathology: The Extinction of a Medical Profession or the Key to a Bright Future?
Show others...
2022 (English)In: Pediatric and Developmental Pathology, ISSN 1093-5266, E-ISSN 1615-5742, Vol. 25, no 4, p. 380-387, article id 10935266211059809Article, review/survey (Refereed) Published
Abstract [en]

Artificial Intelligence (AI) has become of increasing interest over the past decade. While digital image analysis (DIA) is already being used in radiology, it is still in its infancy in pathology. One of the reasons is that large-scale digitization of glass slides has only recently become available. With the advent of digital slide scanners, that digitize glass slides into whole slide images, many labs are now in a transition phase towards digital pathology. However, only few departments worldwide are currently fully digital. Digital pathology provides the ability to annotate large datasets and train computers to develop and validate robust algorithms, similar to radiology. In this opinionated overview, we will give a brief introduction into AI in pathology, discuss the potential positive and negative implications and speculate about the future role of AI in the field of pediatric pathology.

Place, publisher, year, edition, pages
SAGE PUBLICATIONS INC, 2022
Keywords
Artificial Intelligence; deep learning; digital pathology; pediatric pathology
National Category
Other Engineering and Technologies
Identifiers
urn:nbn:se:liu:diva-183756 (URN)10.1177/10935266211059809 (DOI)000765360400001 ()35238696 (PubMedID)2-s2.0-8512581805 (Scopus ID)
Available from: 2022-03-24 Created: 2022-03-24 Last updated: 2025-02-18Bibliographically approved
Hermsen, M., Smeets, B., Hilbrands, L. & van der Laak, J. (2022). Artificial intelligence: is there a potential role in nephropathology?. Nephrology, Dialysis and Transplantation, 37(3), 438-440
Open this publication in new window or tab >>Artificial intelligence: is there a potential role in nephropathology?
2022 (English)In: Nephrology, Dialysis and Transplantation, ISSN 0931-0509, E-ISSN 1460-2385, Vol. 37, no 3, p. 438-440Article in journal (Refereed) Published
Place, publisher, year, edition, pages
Oxford, United Kingdom: Oxford University Press, 2022
National Category
Computer Sciences
Identifiers
urn:nbn:se:liu:diva-183914 (URN)10.1093/ndt/gfaa181 (DOI)000769593600009 ()32995871 (PubMedID)2-s2.0-85123112759 (Scopus ID)
Note

Funding Agencies: ERACoSysMeds SysMIFTA project, as part of the European Union [9003035004]

Available from: 2022-04-04 Created: 2022-04-04 Last updated: 2022-04-26Bibliographically approved
Pinckaers, H., van Ipenburg, J., Melamed, J., De Marzo, A., Platz, E. A., van Ginneken, B., . . . Litjens, G. (2022). Predicting biochemical recurrence of prostate cancer with artificial intelligence. Communications Medicine, 2(1), Article ID 64.
Open this publication in new window or tab >>Predicting biochemical recurrence of prostate cancer with artificial intelligence
Show others...
2022 (English)In: Communications Medicine, E-ISSN 2730-664X, Vol. 2, no 1, article id 64Article in journal (Refereed) Published
Abstract [en]

Background: The first sign of metastatic prostate cancer after radical prostatectomy is rising PSA levels in the blood, termed biochemical recurrence. The prediction of recurrence relies mainly on the morphological assessment of prostate cancer using the Gleason grading system. However, in this system, within-grade morphological patterns and subtle histopathological features are currently omitted, leaving a significant amount of prognostic potential unexplored.

Methods: To discover additional prognostic information using artificial intelligence, we trained a deep learning system to predict biochemical recurrence from tissue in H&E-stained microarray cores directly. We developed a morphological biomarker using convolutional neural networks leveraging a nested case-control study of 685 patients and validated on an independent cohort of 204 patients. We use concept-based explainability methods to interpret the learned tissue patterns.

Results: The biomarker provides a strong correlation with biochemical recurrence in two sets (n = 182 and n = 204) from separate institutions. Concept-based explanations provided tissue patterns interpretable by pathologists.

Conclusions: These results show that the model finds predictive power in the tissue beyond the morphological ISUP grading.

Place, publisher, year, edition, pages
Nature Portfolio, 2022
Keywords
Epidemiology; Prognostic markers; Prostate; Prostate cancer
National Category
Cancer and Oncology
Identifiers
urn:nbn:se:liu:diva-193333 (URN)10.1038/s43856-022-00126-3 (DOI)001023081100002 ()35693032 (PubMedID)
Note

Funding agencies: Dutch Cancer Society under Grant KUN 2015-7970,  the Department of Defense Prostate CancerResearch Program, DOD Award No W81XWH-18-2-0013, W81XWH-18-2-0015,W81XWH-18-2-0016, W81XWH-18-2-0017, W81XWH-18-2-0018, W81XWH-18-2-0019 PCRP Prostate Cancer Biorepository Network (PCBN), DAMD17-03-1-0273, andsupported by Prostate Cancer NCI-NIH grant (P50 CA58236)

Available from: 2023-05-02 Created: 2023-05-02 Last updated: 2024-11-15Bibliographically approved
Sherman, M. E., de Bel, T., Heckman, M. G., White, L. J., Ogony, J., Stallings-Mann, M., . . . van der Laak, J. (2022). Serum hormone levels and normal breast histology among premenopausal women. Breast Cancer Research and Treatment, 194, 149-158
Open this publication in new window or tab >>Serum hormone levels and normal breast histology among premenopausal women
Show others...
2022 (English)In: Breast Cancer Research and Treatment, ISSN 0167-6806, E-ISSN 1573-7217, Vol. 194, p. 149-158Article in journal (Refereed) Published
Abstract [en]

Purpose Breast terminal duct lobular units (TDLUs) are the main source of breast cancer (BC) precursors. Higher serum concentrations of hormones and growth factors have been linked to increased TDLU numbers and to elevated BC risk, with variable effects by menopausal status. We assessed associations of circulating factors with breast histology among premenopausal women using artificial intelligence (AI) and preliminarily tested whether parity modifies associations.

Methods Pathology AI analysis was performed on 316 digital images of H&E-stained sections of normal breast tissues from Komen Tissue Bank donors ages ≤ 45 years to assess 11 quantitative metrics. Associations of circulating factors with AI metrics were assessed using regression analyses, with inclusion of interaction terms to assess effect modification.

Results Higher prolactin levels were related to larger TDLU area (p<0.001) and increased presence of adipose tissue proximate to TDLUs (p<0.001), with less significant positive associations for acini counts (p = 0.012), dilated acini (p = 0.043), capillary area (p = 0.014), epithelial area (p = 0.007), and mononuclear cell counts (p = 0.017). Testosterone levels were associated with increased TDLU counts (p<0.001), irrespective of parity, but associations differed by adipose tissue content. AI data for TDLU counts generally agreed with prior visual assessments.

Conclusion Among premenopausal women, serum hormone levels linked to BC risk were also associated with quantitative features of normal breast tissue. These relationships were suggestively modified by parity status and tissue composition. We conclude that the microanatomic features of normal breast tissue may represent a marker of BC risk.

Place, publisher, year, edition, pages
New York, NY, United States: Springer, 2022
Keywords
Breast cancer risk; Terminal duct lobular units; Hormones; Normal breast tissue
National Category
Cancer and Oncology
Identifiers
urn:nbn:se:liu:diva-185003 (URN)10.1007/s10549-022-06600-9 (DOI)000790168500002 ()35503494 (PubMedID)2-s2.0-85129231951 (Scopus ID)
Note

Funding Agencies: Mayo Clinic Cancer Center [P30CA15083-45]

Available from: 2022-05-17 Created: 2022-05-17 Last updated: 2023-02-28Bibliographically approved
Bokhorst, J. M., Blank, A., Lugli, A., Zlobec, I., Dawson, H., Vieth, M., . . . Nagtegaal, I. D. (2020). Correction to: Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning. Modern Pathology, 33(5)
Open this publication in new window or tab >>Correction to: Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning
Show others...
2020 (English)In: Modern Pathology, ISSN 0893-3952, E-ISSN 1530-0285, Vol. 33, no 5Article in journal (Other academic) Published
Place, publisher, year, edition, pages
Nature Publishing Group, 2020
National Category
Radiology, Nuclear Medicine and Medical Imaging
Identifiers
urn:nbn:se:liu:diva-174285 (URN)10.1038/s41379-019-0450-2 (DOI)000508160800003 ()31900432 (PubMedID)2-s2.0-85077328848 (Scopus ID)
Note

Correction to: Modern Pathology https://doi.org/10.1038/s41379-019-0434-2

Available from: 2021-03-18 Created: 2021-03-18 Last updated: 2021-03-25Bibliographically approved
Hartman, D. J., van der Laak, J., Gurcan, M. N. & Pantanowitz, L. (2020). Value of Public Challenges for the Development of Pathology Deep Learning Algorithms. Journal of Pathology Informatics, 11
Open this publication in new window or tab >>Value of Public Challenges for the Development of Pathology Deep Learning Algorithms
2020 (English)In: Journal of Pathology Informatics, ISSN 2229-5089, E-ISSN 2153-3539, Journal of pathology informatics, Vol. 11Article in journal, Editorial material (Refereed) Published
Abstract [en]

The introduction of digital pathology is changing the practice of diagnostic anatomic pathology. Digital pathology offers numerous advantages over using a physical slide on a physical microscope, including more discriminative tools to render a more precise diagnostic report. The development of these tools is being facilitated by public challenges related to specific diagnostic tasks within anatomic pathology. To date, 24 public challenges related to pathology tasks have been published. This article discusses these public challenges and briefly reviews the underlying characteristics of public challenges and why they are helpful to the development of digital tools.

Place, publisher, year, edition, pages
Medknow Publications, 2020
Keywords
Algorithm development; artificial intelligence; digital pathology algorithms; public challenges
National Category
Information Systems, Social aspects
Identifiers
urn:nbn:se:liu:diva-174231 (URN)10.4103/jpi.jpi_64_19 (DOI)32318315 (PubMedID)2-s2.0-85085369885 (Scopus ID)
Available from: 2021-03-17 Created: 2021-03-17 Last updated: 2024-11-25Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0001-7982-0754

Search in DiVA

Show all publications